Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
2.700
-0.170 (-5.92%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Company Description
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.
It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories.
The company was founded in 2011 and is headquartered in Laguna Hills, California.
Adagio Medical Holdings, Inc.
Country | United States |
Founded | 2011 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 85 |
CEO | Olav Bergheim |
Contact Details
Address: 26051 Merit Circle, Suite 102 Laguna Hills, California 92653 United States | |
Phone | 949-348-1188 |
Website | adagiomedical.com |
Stock Details
Ticker Symbol | ADGM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0002006986 |
ISIN Number | US00534B1008 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Olav B. Bergheim | President, Chief Executive Officer, Secretary and Executive Director |
John T. Dahldorf | Chief Financial Officer |
Hakon Bergheim | Chief Operating Officer |
Dr. Alex Babkin Ph.D. | Chief Technical Officer |
Nabil Jubran | Chief Compliance Officer |
Ilya Grigorov | Vice President of Global Marketing and Product Management |
Tim Glynn | Vice President of Global Sales |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 8, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Sep 19, 2024 | EFFECT | Notice of Effectiveness |
Sep 19, 2024 | EFFECT | Notice of Effectiveness |
Sep 19, 2024 | 424B3 | Prospectus |
Sep 19, 2024 | 424B3 | Prospectus |
Sep 17, 2024 | UPLOAD | Filing |
Sep 17, 2024 | UPLOAD | Filing |
Sep 13, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Sep 13, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Aug 26, 2024 | 10-Q | Quarterly Report |